Logo-jnp
J Nephropathol. 2018;7(3): 182-187. doi: 10.15171/jnp.2018.38

Original Article

Soluble urokinase-type plasminogen activator receptor as a biomarker for focal segmental glomerulosclerosis; a retrospective analysis

Miguel Verdelho 1, Ana Carina Ferreira 1 * , Maria Céu Santos 2, Mário Góis 1, Helena Viana 1, Fernanda Carvalho 1, Francisco Ribeiro 1, Fernando Nolasco 1

Cited by CrossRef: 3

1- Le Thy P, Hoang Thi T, Tran K, Nguyen H. Soluble urokinase plasminogen activator receptor (suPAR) and glomerular disease in children: a narrative review. Egypt Pediatric Association Gaz. 2022;70(1) [Crossref]
2- Thy P, Tran K, Thi T, Thi M, Nguyen H. The value of urinary soluble urokinase plasminogen activator receptor (suPAR) in children with nephrotic syndrome. 2021;8(2):163 [Crossref]
3- Shuai T, Pei Jing Y, Huang Q, Xiong H, Liu J, Zhu L, Yang K, Jian L. Serum soluble urokinase type plasminogen activated receptor and focal segmental glomerulosclerosis: a systematic review and meta-analysis. BMJ Open. 2019;9(10):e031812 [Crossref]